Skip to main content
logo
Iambic Therapeutics, Inc. (IAM)
NASDAQ: IAM · Real-Time Price · USD
14.67
-1.13 (-7.15%)
At close: Oct 22, 2026, 4:00 PM EDT
14.30
-0.37 (-2.52%)
Pre-market: Oct 23, 2026, 5:05 AM EDT

Iambic Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Market Capitalization
695--
Market Cap Growth
---
Enterprise Value
493--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Debt / Equity Ratio
0.030.040.05
Net Debt / Equity Ratio
-1.25-1.13-1.04
Net Debt / EBITDA Ratio
2.052.162.56
Net Debt / FCF Ratio
2.972.913.94
Asset Turnover
-0.05-
Quick Ratio
4.516.928.41
Current Ratio
4.596.988.52
Return on Equity (ROE)
--54.21%-
Return on Assets (ROA)
--29.35%-
Return on Capital Employed (ROCE)
-53.10%-48.80%-38.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Buyback Yield / Dilution
--0.93%-
SEC Filings: 10-K · 10-Q